Article
Immunology
Seok Won Jin, Yeonggeul Lee, Sohye Lee, Haeun Jin, Heather M. Brandt
Summary: This study examined HPV vaccination among college students in the Mid-South region of the United States and explored preferred promotion strategies. The results indicated that HPV vaccine knowledge and perceived barriers were factors influencing vaccination coverage for both male and female students, while perceived risks of HPV and vaccine hesitancy only affected female students. The findings from the survey study were corroborated by the qualitative content analysis, identifying barriers and preferred strategies for vaccination promotion among college students. These findings have implications for tailored interventions to improve HPV vaccine uptake in the Mid-South region. Further research and implementation of effective strategies are urgently needed to address the identified barriers.
Article
Oncology
Yuko Watanabe, Yutaka Ueda, Asami Yagi, Sayaka Ikeda, Emiko Oka, Mamoru Kakuda, Satoshi Nakagawa, Kosuke Hiramatsu, Ai Miyoshi, Eiji Kobayashi, Toshihiro Kimura, Tadashi Kimura
Summary: In November 2021, the Japanese government reversed its 2013 decision to suspend the proactive recommendation for HPV vaccination. However, the implementation of routine and catch-up vaccinations for young girls did not go as planned. A nationwide questionnaire survey conducted in September 2022 revealed disparities among municipalities in their HPV vaccine notification processes. Monitoring HPV vaccination rates and incidence rates of cervical cancer and precancerous lesions in each municipality will be important for future research.
Article
Medicine, General & Internal
Gui Liu, Nelly R. Mugo, Cara Bayer, Darcy White Rao, Maricianah Onono, Nyaradzo M. Mgodi, Zvavahera M. Chirenje, Betty W. Njoroge, Nicholas Tan, Elizabeth A. Bukusi, Ruanne Barnabas
Summary: Cervical cancer incidence is high in Kenya due to HIV and limited access to cancer prevention services. HPV vaccination can substantially reduce cervical cancer incidence in Kenya, particularly among women up to the age of 24.
Article
Multidisciplinary Sciences
Antoine Elies, Claire Bonneau, Sophie Houzard, Roman Rouzier, Delphine Hequet
Summary: This study evaluated the impact of catch-up HPV vaccination on a specific surgical procedure in a large population-based study in France. The results showed that HPV vaccination reduced the risk of this procedure in women aged 19 to 30.
Article
Oncology
Satoshi Nakagawa, Asami Yagi, Yutaka Ueda, Sayaka Ikeda, Mamoru Kakuda, Kosuke Hiramatsu, Ai Miyoshi, Toshihiro Kimura, Kei Hirai, Masayuki Sekine, Tomio Nakayama, Eiji Kobayashi, Etsuko Miyagi, Takayuki Enomoto, Tadashi Kimura
Summary: Our survey showed that the intention to receive catch-up vaccination varied depending on the vaccination history. Factors such as gynecological visits, willingness to undergo cervical cancer screening, sexual activity, anxiety about cervical cancer, familiarity with cervical cancer-related issues, experience with vaccination recommendations, and knowledge about cervical cancer were found to be associated with the intention to uptake catch-up HPV vaccination (p < 0.05, respectively). Moreover, there was a significant difference in vaccination intention between the vaccinated generation and the vaccine-suspended generation (p < 0.05).
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
(2023)
Article
Immunology
Dominik Pruski, Malgorzata Lagiedo-Zelazowska, Sonja Millert-Kalinska, Jan Sikora, Robert Jach, Marcin Przybylski
Summary: The study found that levels of antibodies in vaccinated individuals were significantly higher than those in the unvaccinated control group. This indicates that HPV vaccination may be beneficial for patients after sexual initiation, as well as those already diagnosed with HPV or cervical intraepithelial lesion (SIL) infection.
Article
Public, Environmental & Occupational Health
Kay Htaik, Christopher K. K. Fairley, Marcus Y. Y. Chen, Rebecca Wigan, Elena Rodriguez, Catriona S. S. Bradshaw, Eric P. F. Chow
Summary: Less than one-third of men aged 26 and under completed the three-dose HPV vaccine regimen. Factors associated with completion included sexual orientation and HIV status, with gay men and HIV-positive men more likely to complete the vaccination series. Further studies are needed to understand barriers to completion among men who have sex with men.
FRONTIERS IN PUBLIC HEALTH
(2021)
Article
Public, Environmental & Occupational Health
Ilkka Kalliala, Tiina Eriksson, Karoliina Aro, Mari Hokkanen, Matti Lehtinen, Mika Gissler, Pekka Nieminen
Summary: The study found that the rates of preterm birth, especially early preterm birth, were lower among women who received HPV vaccination, indicating that prophylactic HPV vaccination may help reduce preterm birth rates.
PREVENTIVE MEDICINE
(2021)
Article
Public, Environmental & Occupational Health
Joost J. M. Simons, Tjalke A. Westra, Maarten J. Postma
Summary: The Health Council of the Netherlands recommends HPV vaccination for both boys and girls, and a catch-up program for males up to age 26. The study shows that vaccinating males can prevent a significant number of cancer cases with an acceptable cost-effectiveness ratio.
PREVENTIVE MEDICINE REPORTS
(2022)
Article
Immunology
Giuseppe Murdaca, Giovanni Noberasco, Dario Olobardi, Claudio Lunardi, Matteo Maule, Lorenzo Delfino, Massimo Triggiani, Chiara Cardamone, Devis Benfaremo, Gianluca Moroncini, Angelo Vacca, Nicola Susca, Sebastiano Gangemi, Paola Quattrocchi, Laura Sticchi, Giancarlo Icardi, Andrea Orsi
Summary: This paper provides up-to-date evidence on vaccination strategies for patients with systemic sclerosis (SSc) to help prevent and manage infectious diseases, covering a range of vaccines including SARS-CoV-2, seasonal influenza, and others.
Article
Virology
Laura Teblick, Jade Pattyn, Severien Van Keer, Annemie De Smet, Ilse De Coster, Wiebren A. A. Tjalma, Ira Rajbhandari, Gitika Panicker, Elizabeth R. Unger, Alex Vorsters
Summary: This study explores the potential use of first-void urine as a noninvasive alternative sample for assessing humoral immune responses following HPV vaccination. The results show that first-void urine can detect HPV-specific antibody concentrations, with significant correlations to serum samples at different time points.
JOURNAL OF MEDICAL VIROLOGY
(2023)
Article
Public, Environmental & Occupational Health
Ansley V. Waters, Laura K. Merrell, Erika L. Thompson
Summary: The study found that females in monogamous relationships were less likely to participate in catch-up vaccination for HPV. This may be due to a lower perception of sexually transmitted disease risk among these women. Public health practitioners should pay special attention to communicating HPV risk to women in monogamous relationships.
JOURNAL OF WOMENS HEALTH
(2021)
Article
Immunology
Rosa De Vincenzo, Nicola Caporale, Valentina Bertoldo, Caterina Ricci, Maria Teresa Evangelista, Nicolo Bizzarri, Luigi Pedone Anchora, Giovanni Scambia, Giovanni Capelli
Summary: This study evaluated the effect of 9-valent HPV vaccination on HPV and cytological test results in adult women. The results showed a significant reduction in clearance time for HPV HR+ and Pap positivity in women who received the third dose of the vaccine.
Article
Public, Environmental & Occupational Health
Yimeng Mao, Yuchen Zhao, Lingyun Zhang, Jie Li, Abu S. Abdullah, Pinpin Zheng, Fan Wang
Summary: This study aimed to assess the frequency and factors associated with healthcare providers' (HCPs) recommendations for HPV vaccination. Results showed that only 30.2% of participants frequently recommended HPV vaccination. Factors associated with a higher recommendation frequency included female sex, employment in obstetrics or gynecology departments and community health service centers, and higher knowledge of HPV. Factors such as perceiving no obligation to provide recommendations and difficulties in discussing sexual topics were correlated with less frequent recommendations. Employment in a community health service center was the strongest factor associated with the frequency of HCPs' recommendations for HPV vaccination.
FRONTIERS IN PUBLIC HEALTH
(2023)
Review
Immunology
Edith Morais, Nadia El Mouaddin, Susanne Schuurman, Atish De
Summary: Head and neck cancers, particularly those related to HPV, pose a significant burden worldwide, with a higher incidence in men. Evaluations of HPV gender-neutral vaccination programs by European countries suggest that they are likely to be cost-effective.